Transition Therapeutics Inc. — Investor Relations & Filings
Filings indexed
137
across all filing types
Latest filing
2016-10-11
Regulatory Filings
Country
CA
Canada
Listing
TSX
TTH
Transition Therapeutics is a biopharmaceutical company dedicated to the research and development of novel therapeutic agents for disease indications with large global markets. The company focuses on developing small molecule therapeutics primarily targeting CNS (Central Nervous System) and metabolic diseases, including treatments for Alzheimer's disease and diabetes. Its pipeline includes a lead drug candidate that has completed Phase II clinical trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Notice (amended).pdf | 2016-10-11 | English | |
| Notice.pdf | 2016-09-15 | English | |
| Material change report - English.pdf | 2016-09-09 | English | |
| News release - English.pdf | 2016-08-26 | English | |
| Report of voting results.pdf | 2016-08-26 | English | |
| Form of proxy - English.pdf | 2016-08-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2016
15 filings
| |||||
| 47109549 | Notice (amended).pdf | 2016-10-11 | English | ||
| 47109550 | Notice.pdf | 2016-09-15 | English | ||
| 47109551 | Material change report - English.pdf | 2016-09-09 | English | ||
| 47109556 | News release - English.pdf | 2016-08-26 | English | ||
| 47109557 | Report of voting results.pdf | 2016-08-26 | English | ||
| 47109558 | Form of proxy - English.pdf | 2016-08-04 | English | ||
| 47109597 | Other.pdf | 2016-08-04 | English | ||
| 47109617 | Notice of the meeting and record date - English.pdf | 2016-07-13 | English | ||
| 47109618 | Material change report - English.pdf | 2016-07-06 | English | ||
| 47109619 | Other.pdf | 2016-07-06 | English | ||
| 47109620 | News release - English.pdf | 2016-06-30 | English | ||
| 47109621 | News release - English.pdf | 2016-06-03 | English | ||
| 47109626 | News release - English.pdf | 2016-05-11 | English | ||
| 47109642 | Interim MD&A - English.pdf | 2016-05-11 | English | ||
| 47109643 | Other.pdf | 2016-05-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
MAXCYTE, INC.
A cell-engineering company with a platform for developing c…
|
MXCT | US | Professional, scientific and te… |
|
Medicenna Therapeutics Corp.
A clinical-stage immunotherapy company developing novel eng…
|
MDNA | CA | Professional, scientific and te… |
|
Medicofarma Biotech Spolka Akcyjna
R&D company developing innovative medicines, medical device…
|
MDB | PL | Professional, scientific and te… |
|
Medigene AG
Develops TCR-guided immunotherapies for cancer; currently i…
|
MDG1 | DE | Professional, scientific and te… |
|
Medizen Humancare Inc Co., Ltd
A research company specializing in genomic analysis for per…
|
236340 | KR | Professional, scientific and te… |
|
Medpace Holdings, Inc.
A global CRO providing Phase I-IV clinical development for …
|
MEDP | US | Professional, scientific and te… |
|
MegaPro Biomedical Co. Ltd.
A clinical-stage biotech developing nanomedicines for oncol…
|
— | MY | Professional, scientific and te… |
|
MEMPHASYS LIMITED.
Develops cell separation solutions for human and animal rep…
|
MEM | AU | Professional, scientific and te… |
|
Metagenomi, Inc.
A genetic medicines company developing therapeutics with a …
|
MGX | US | Professional, scientific and te… |
|
MICROBA LIFE SCIENCES LIMITED
Analyzes gut microbiomes using metagenomic sequencing for t…
|
MAP | AU | Professional, scientific and te… |
Transition Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45117/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45117 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45117 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45117 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45117}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Transition Therapeutics Inc. (id: 45117)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.